Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome [Incremento de lipoproteína(a) en paciente pediátrico asociado a síndrome nefrótico]
dc.creator | Menéndez Valladares P. | |
dc.creator | Arrobas Velilla T. | |
dc.creator | Bermúdez de la Vega J.A. | |
dc.creator | Romero Pérez M.D.M. | |
dc.creator | Fabiani Romero F. | |
dc.creator | González Rodríguez C. | |
dc.date.accessioned | 2020-09-02T22:22:57Z | |
dc.date.accessioned | 2022-11-08T20:25:38Z | |
dc.date.available | 2020-09-02T22:22:57Z | |
dc.date.available | 2022-11-08T20:25:38Z | |
dc.date.created | 2020-09-02T22:22:57Z | |
dc.date.issued | 2016 | |
dc.identifier | 28, 5, 227-229 | |
dc.identifier | 02149168 | |
dc.identifier | https://hdl.handle.net/20.500.12728/5311 | |
dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/5145746 | |
dc.language | en | |
dc.language | es | |
dc.publisher | Elsevier Doyma | |
dc.subject | LDL-cholesterol | |
dc.subject | Lipoprotein(a) | |
dc.subject | Nephrotic syndrome | |
dc.subject | Paediatrics | |
dc.subject | apolipoprotein B100 | |
dc.subject | atorvastatin | |
dc.subject | lipoprotein A | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | tacrolimus | |
dc.subject | triacylglycerol | |
dc.subject | apolipoprotein B100 | |
dc.subject | immunosuppressive agent | |
dc.subject | lipoprotein A | |
dc.subject | low density lipoprotein cholesterol | |
dc.subject | Article | |
dc.subject | cardiovascular risk | |
dc.subject | case report | |
dc.subject | causal attribution | |
dc.subject | child | |
dc.subject | cholesterol blood level | |
dc.subject | drug effect | |
dc.subject | dyslipidemia | |
dc.subject | human | |
dc.subject | lipoprotein blood level | |
dc.subject | male | |
dc.subject | nephrotic syndrome | |
dc.subject | preschool child | |
dc.subject | triacylglycerol blood level | |
dc.subject | blood | |
dc.subject | complication | |
dc.subject | Dyslipidemias | |
dc.subject | nephrotic syndrome | |
dc.subject | pathophysiology | |
dc.subject | prognosis | |
dc.subject | risk factor | |
dc.subject | Apolipoprotein B-100 | |
dc.subject | Atorvastatin Calcium | |
dc.subject | Child, Preschool | |
dc.subject | Cholesterol, LDL | |
dc.subject | Dyslipidemias | |
dc.subject | Humans | |
dc.subject | Immunosuppressive Agents | |
dc.subject | Lipoprotein(a) | |
dc.subject | Male | |
dc.subject | Nephrotic Syndrome | |
dc.subject | Prognosis | |
dc.subject | Risk Factors | |
dc.subject | Tacrolimus | |
dc.title | Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome [Incremento de lipoproteína(a) en paciente pediátrico asociado a síndrome nefrótico] | |
dc.type | Article |